A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study

MLA

Yanyan Liu, et al. “A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study.” Diabetes Therapy, vol. 8, Feb. 2017, pp. 385–99. EBSCOhost, https://doi.org/10.1007/s13300-017-0238-7.

APA

Yanyan Liu, Shin-ichi Harashima, Kiminori Hosoda, Akiko Nishimura, Yu Wang, Nobuya Inagaki, & Haruna Fukushige. (2017). A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study. Diabetes Therapy, 8, 385–399. https://doi.org/10.1007/s13300-017-0238-7

Chicago

Yanyan Liu, Shin-ichi Harashima, Kiminori Hosoda, Akiko Nishimura, Yu Wang, Nobuya Inagaki, and Haruna Fukushige. 2017. “A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study.” Diabetes Therapy 8 (February): 385–99. doi:10.1007/s13300-017-0238-7.